Leonteq Securities’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
Leonteq Securities's MDGL Position: Q3 2026 in Review
Leonteq Securities increased its Madrigal Pharmaceuticals (MDGL) stake by 3.3% in Q3 2026, buying an estimated $528 and bringing the position to 31 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #964.
Leonteq Securities first reported a position in MDGL in Q4 2022 and has held it in 8 quarters since. The position peaked at $136K in Q4 2022. 338 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- Leonteq Securities held 31 shares of Madrigal Pharmaceuticals worth $15.6K as of Q3 2026.
- Leonteq Securities bought 1 Madrigal Pharmaceuticals share in Q3 2026, an estimated $528.
- Madrigal Pharmaceuticals made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #964 holding.
- Leonteq Securities first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
- Leonteq Securities's Madrigal Pharmaceuticals position peaked at $136K in Q4 2022.
- 338 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.